Upper tract tumors in patients with primary bladder cancer followed for 15 years.

Harry W. Herr(Memorial Sloan Kettering Cancer Center), Scott M. Soloway(Memorial Sloan Kettering Cancer Center), Michael S. Cookson(University of Oklahoma Health Sciences Center)

PubMed

October 1, 1996

Cited by 102

Related Papers

Guideline for the Management of Clinically Localized Prostate Cancer: 2007 Update

|The Journal of Urology|2007|1.1k

Variation in the Definition of Biochemical Recurrence in Patients Treated for Localized Prostate Cancer: The American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel Report and Recommendations for a Standard in the Reporting of Surgical Outcomes

|The Journal of Urology|2007|845

Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial

|The Lancet|2018|779

The Treated Natural History of High Risk Superficial Bladder Cancer: 15-year Outcome

|The Journal of Urology|1997|555

CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma

|Proceedings of the National Academy of Sciences|2007|517